MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-17-2026
Accuray Incorporated Interest Expense 2011-2026 | ARAY
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Accuray Incorporated
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 559 K | -2.54 M | 10.6 M | 8.13 M | 16.9 M | 18.1 M | 15.1 M | 15 M | -18.7 M | -18.3 M | -18.6 M | 162 K | 252 K | -12.5 M | 2.29 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 18.1 M | -18.7 M | 1.09 M |
Quarterly Interest Expense Accuray Incorporated
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -106 K | 8.05 M | - | 2.89 M | -196 K | 2.96 M | - | 2.88 M | 2.92 M | 2.92 M | - | 2.72 M | 2.64 M | 2.26 M | 4.91 M | 1.98 M | 2.08 M | 2.04 M | 4.12 M | -4.03 M | -4.26 M | -4.69 M | -4.26 M | -4.69 M | 7.77 M | -4.44 M | 7.77 M | -4.44 M | -3.32 M | -3.98 M | -3.32 M | -3.98 M | -3.74 M | -6.57 M | -3.74 M | -6.57 M | -4.12 M | -4 M | -4.12 M | -4 M | -5.07 M | -5.09 M | -5.07 M | -5.09 M | -5.53 M | -5.46 M | -5.53 M | -5.46 M | -3.78 M | -2.46 M | -3.78 M | -2.46 M | -2.58 M | -704 K | -2.58 M | -747 K | -4.46 M | -2.86 M | -4.51 M | -2.86 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 8.05 M | -6.57 M | -1.72 M |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AdaptHealth Corp.
AHCO
|
-274 K | $ 12.86 | -1.72 % | $ 1.74 B |  USA |
 |
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | USA |
 |
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | USA |
 |
Electromed
ELMD
|
78 K | $ 25.1 | -0.59 % | $ 212 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | USA |
 |
EDAP TMS S.A.
EDAP
|
232 K | $ 3.36 | 1.46 % | $ 126 M |  France |
 |
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | USA |
 |
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | USA |
 |
BioSig Technologies
BSGM
|
1.6 M | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
-146 K | $ 10.57 | 2.2 % | $ 299 M | USA |
 |
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | USA |
 |
Helius Medical Technologies
HSDT
|
46.9 K | $ 2.0 | 1.01 % | $ 1.22 M | USA |
 |
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
549 K | - | - | $ 10.2 M | USA |
 |
Neovasc
NVCN
|
133 K | - | - | $ 111 M |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 14.76 | 0.82 % | $ 346 M | USA |
 |
Butterfly Network
BFLY
|
-13 K | $ 4.28 | -13.01 % | $ 906 M | USA |
 |
Second Sight Medical Products
EYES
|
947 K | - | -0.97 % | $ 54.4 M | USA |
 |
LivaNova PLC
LIVN
|
664 K | $ 58.53 | -0.66 % | $ 3.19 B |  Britain |
 |
Globus Medical
GMED
|
3.41 M | $ 88.23 | 0.49 % | $ 11.9 B | USA |
 |
Delcath Systems
DCTH
|
-70 K | $ 10.25 | 0.39 % | $ 367 M | USA |
 |
Insulet Corporation
PODD
|
14.3 M | $ 169.75 | 6.08 % | $ 11.9 B | USA |
 |
CONMED Corporation
CNMD
|
31.1 M | $ 38.59 | 7.31 % | $ 1.2 B | USA |
 |
Inspire Medical Systems
INSP
|
-2.66 M | $ 53.41 | - | $ 1.57 B | USA |
 |
Sintx Technologies
SINT
|
31 K | $ 2.0 | 0.5 % | $ 5.55 M | USA |
 |
Integer Holdings Corporation
ITGR
|
-53.2 M | $ 83.01 | -0.79 % | $ 2.88 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
7.2 M | $ 80.96 | -0.32 % | $ 47.3 B | USA |
 |
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | USA |
 |
TELA Bio
TELA
|
1.29 M | $ 0.84 | -1.79 % | $ 39.4 M | USA |
 |
TransMedics Group
TMDX
|
3.87 M | $ 98.83 | 0.26 % | $ 3.36 B | USA |
 |
Tandem Diabetes Care
TNDM
|
-13 M | $ 18.77 | 3.33 % | $ 1.28 B | USA |
 |
LENSAR
LNSR
|
636 K | $ 5.38 | -0.19 % | $ 64.3 M | USA |
 |
Pulmonx Corporation
LUNG
|
790 K | $ 1.25 | 4.17 % | $ 50.9 M | USA |